Inzy stock forecast.
Next reporting date. February 23, 2024. EPS forecast (this quarter) -$0.39. Annual revenue (last year) $17.9M. Annual profit (last year) -$229.8M. Net profit margin.
Track Inozyme Pharma Inc (INZY) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investorsSep 20, 2023 · Inozyme Pharma, Inc. (INZY) share price prediction for 2023, 2024, 2025, 2026 and 2027. INZY one year forecast. Inozyme Pharma stock monthly and weekly forecasts. Find the latest Inozyme Pharma, Inc. (INZY) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.President exercised options and sold US$65k worth of stock Jun 26. Inozyme Pharma, Inc. Announces Acceptance of First European Clinical Trial Application …
Find the latest Pyxis Oncology, Inc. (PYXS) stock quote, history, news and other vital information to help you with your stock trading and investing.
Nov 24, 2023 · Stock Price Forecast. According to 16 stock analysts, the average 12-month stock price forecast for Incyte stock is $79.25, which predicts an increase of 47.47%. The lowest target is $60 and the highest is $100. On average, analysts rate Incyte stock as a buy.
BOSTON, March 15, 2022 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics …Inozyme Pharma Inc. 3.23. Delayed Data. As of Nov 16. +0.03 / +0.94%. Today’s Change. 0.99. Today ||| 52-Week Range. 7.33.View YPF Sociedad Anonima YPF investment & stock information. Get the latest YPF Sociedad Anonima YPF detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Find the latest EBET, Inc. (EBET) stock quote, history, news and other vital information to help you with your stock trading and investing.Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.
In today’s fast-paced business environment, accurate forecasting is crucial for making informed decisions and staying ahead of the competition. One powerful tool that can help you achieve this is a forecasting Excel template.
Price Action: INZY shares are up 26.6% at $2.81 during the premarket session on the last check Thursday. Don't miss real-time alerts on your stocks - join Benzinga Pro for free!
Inozyme Pharma Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. ... The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction. ... INZY Related stocks. Symbol 3M %Chg ; INZY -36.16% : Inozyme Pharma Inc: AMGN +3 ...You can buy or sell Inozyme Pharma and other ETFs, options, and stocks. View the real-time INZY price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees, Gold subscription fees, wire transfer fees, and paper statement fees may apply. See Robinhood Financial’s fee schedule ...According to our current INZY stock forecast, the value of Inozyme Pharma shares will rise by 7.27% and reach $ 3.50 per share by November 24, 2023. According to our technical indicators, the current sentiment is Bearish while the Fear & Greed Index is showing 39 (Fear). Find the latest MAIA Biotechnology, Inc. (MAIA) stock quote, history, news and other vital information to help you with your stock trading and investing.We've seen plenty of personal finance tools designed to help you track what you're spending, but web site PocketSmith is an impressive new web-based personal finance tool with an emphasis on forecasting your financial future. We've seen ple...4 Wall Street research analysts have issued 12 month price targets for Argo Blockchain's stock. Their ARBK share price targets range from $1.45 to $2.75. On average, they expect the company's stock price to reach $2.23 in the next twelve months. This suggests a possible upside of 90.9% from the stock's current price.
According to the issued ratings of 4 analysts in the last year, the consensus rating for Inozyme Pharma stock is Buy based on the current 4 buy ratings for INZY. The average twelve-month price prediction for Inozyme Pharma is $15.00 with a high price target of $23.00 and a low price target of $6.00. Learn more on INZY's analyst rating history.November 29, 2023 at 2:12 PM PST. Listen. 1:37. Victoria’s Secret & Co. reported a larger-than-expected quarterly loss amid a rise in investment in marketing and technology, …Inozyme Pharma, Inc. (INZY) stock forecast and price target. Find the latest Inozyme Pharma, Inc. INZY analyst stock forecast, price target, and recommendation trends with in-depth analysis from ... Stock Price Forecast. The 18 analysts offering 12-month price forecasts for Incyte Corp have a median target of 71.00, with a high estimate of 93.00 and a low estimate of 58.00. The median ... Stock Price Forecast. The 15 analysts offering 12-month price forecasts for Paycom Software Inc have a median target of 190.00, with a high estimate of 270.00 and a low estimate of 140.00. The ...What is Incyte's Market Cap? ( NASDAQ: INCY) Incyte 's market cap is $11.75B, as of Nov 12, 2023. Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares. Incyte 's market cap is calculated by multiplying INCY 's current stock price of $52.44 by INCY 's total outstanding shares of 224,109,238.
Based on short-term price targets offered by 16 analysts, the average price target for Incyte comes to $75.44. The forecasts range from a low of $59.00 to a high of $93.00. The average price ...What is Incyte's Market Cap? ( NASDAQ: INCY) Incyte 's market cap is $11.75B, as of Nov 12, 2023. Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares. Incyte 's market cap is calculated by multiplying INCY 's current stock price of $52.44 by INCY 's total outstanding shares of 224,109,238.
Find the latest Plus Therapeutics, Inc. (PSTV) stock quote, history, news and other vital information to help you with your stock trading and investing.4 Wall Street research analysts have issued 12 month price targets for Argo Blockchain's stock. Their ARBK share price targets range from $1.45 to $2.75. On average, they expect the company's stock price to reach $2.23 in the next twelve months. This suggests a possible upside of 90.9% from the stock's current price.Join Seeking Alpha, the largest investing community in the world. Get stock market news and analysis, investing ideas, earnings calls, charts and portfolio analysis tools.Federated Hermes: bullish, S&P 500 price target of 5,000. Strong underlying trends in the stock market are likely to extend well into 2024, according to Federated …Dec 1, 2023 · View Inozyme Pharma, Inc INZY investment & stock information. Get the latest Inozyme Pharma, Inc INZY detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.Track Inozyme Pharma Inc (INZY) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors. Join the Conversation! Build your trading network; Follow your favorite assets ...Stock analysis for Inozyme Pharma Inc (INZY:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Get the latest Inozyme Pharma Inc (INZY) stock quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. See the company's financial results, market news, and earnings per share for the fiscal Q2 2023 ended 6/30/23. The weighted average target price per Incyte share in Dec 2023 is: 52.02. In Dec, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 3.880% volatility is expected. Pessimistic target level: 51.04. Optimistic target level: 53.10. Incyte stock price predictions for 2023 using artificial intelligence.
A shelf registration statement on Form S-3 (File No. 333-258702) relating to the shares of common stock offered in the public offering was filed with the Securities and Exchange Commission (the ...
Dec 1, 2023 · 19 Wall Street analysts have issued 1-year price objectives for Incyte's stock. Their INCY share price targets range from $61.00 to $100.00. On average, they expect the company's share price to reach $79.94 in the next year. This suggests a possible upside of 48.0% from the stock's current price.
Find the latest Vyant Bio, Inc. (VYNT) stock quote, history, news and other vital information to help you with your stock trading and investing.A high-level overview of Inozyme Pharma, Inc. (INZY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.What this means: Inozyme Pharma Inc (INZY) gets an Overall Rank of 67, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value.Weather forecasting plays a crucial role in our daily lives, helping us plan our activities and make informed decisions. But have you ever wondered how meteorologists are able to accurately predict the weather? One of the key components in ...You can buy or sell Inozyme Pharma and other ETFs, options, and stocks. View the real-time INZY price chart on Robinhood and decide if you want to buy or sell commission-free. Other fees such as trading (non-commission) fees, Gold subscription fees, wire transfer fees, and paper statement fees may apply. See Robinhood Financial’s fee schedule ...Find the latest Atreca, Inc. (BCEL) stock quote, history, news and other vital information to help you with your stock trading and investing.Nov 29, 2023 · Their INZY share price targets range from $6.00 to $23.00. On average, they predict the company's stock price to reach $15.00 in the next year. This suggests a possible upside of 289.6% from the stock's current price. View analysts price targets for INZY or view top-rated stocks among Wall Street analysts. SEMR | Complete SEMrush Holdings Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
Find the latest Plus Therapeutics, Inc. (PSTV) stock quote, history, news and other vital information to help you with your stock trading and investing.View Inozyme Pharma, Inc INZY investment & stock information. Get the latest Inozyme Pharma, Inc INZY detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.Nov 24, 2023 · Stock Price Forecast. According to 16 stock analysts, the average 12-month stock price forecast for Incyte stock is $79.25, which predicts an increase of 47.47%. The lowest target is $60 and the highest is $100. On average, analysts rate Incyte stock as a buy. Instagram:https://instagram. goldman sachs business credit cardbest ppo health insurance in floridaphilosophy winerystandard property management fee Find the latest VYNE Therapeutics Inc. (VYNE) stock quote, history, news and other vital information to help you with your stock trading and investing.According to our current INZY stock forecast, the value of Inozyme Pharma shares will rise by 7.27% and reach $ 3.50 per share by November 24, 2023. According to our technical indicators, the current sentiment is Bearish while the Fear & Greed Index is showing 39 (Fear). meet beagle reviewvanguard large cap etf It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it happened in Inozyme Pharma, Inc.'s (NASDAQ:INZY) case, it's fantastic news for ...See Inozyme Pharma, Inc. (INZY) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. stocks in cash app Analyzing the anticipated performance of Incyte, the ceiling value that the stock is expected to reach in 2025 stands at a promising $79.7.Indicating a bullish trend, an upside potential of 40.27% signals profitable prospects, with an average monthly return of 1.55%, beckoning investors to consider amplifying their portfolios.People use statistics daily for weather forecasts, predicting disease, preparing for emergencies, medical research, political campaigns, tracking sales, genetics, insurance, the stock market and quality testing.The average price target for Inozyme Pharma's stock set by recognized analysts recently is $23.00, which would result in a potential upside of approximately …